Biocept

BIOC NASDAQ
1.030
-0.000
-0.01%
盘后: 1.030 0 0.01% 17:23 07/19 EDT
开盘
1.030
昨收
1.030
最高
1.040
最低
1.010
成交量
22.34万
成交均量(3M)
367.03万
52周最高
7.23
52周最低
0.6580
换手率
1.18%
市值
1,943.16万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Biocept BIOC股票价格,Biocept股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Biocept, Inc. is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The Company's Target-Selector offering is based on an internally developed, microfluidics-based CTC capture and analysis platform, with enabling features that change how CTC testing can be used by clinicians by providing biomarker detection and monitoring requiring only a standard blood sample. The ctDNA technology enables mutation detection and is applicable to nucleic acid from CTCs or other sample types, such as blood plasma. The Company commercializes its Target-Selector assays for a range of solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), gastric cancer, colorectal cancer, prostate cancer and melanoma.
展开 >

最近浏览

名称
价格
涨跌幅